Left: tissue accumulation over time

Left: tissue accumulation over time. models for nanomedicine evaluations, categorized into seven broad sections based on the target organ systems: respiratory, digestive, Propyzamide lymphatic, excretory, nervous, and vascular, as well as coverage on applications relating to cancer. We conclude by providing our perspectives Propyzamide on the challenges and potential future directions for applications of Organ Chip in nanomedicine. ((and em E. coli /em . (C) Schematic of a venous sinus in the red pulp of the spleen (left), longitudinal view of the biospleen (right), and a photograph of the engineered device (top right). Reproduced from Reference [92]. Copyright 2014?Nature Publishing Group. Outlook of using Spleen Chip in the study of nanomedicine. In the future, it would be interesting to examine the role of the biological cell components of the spleen in homeostatic and pathological filtration processes. Additionally, since the inter-endothelial slits in the human spleen are approximately 200?nm, nanoparticles larger than 200?nm are expected to accumulate in the spleen [134,135]. There is, therefore, an opportunity to investigate the behavior of deformable nanoparticles and also to achieve a more comprehensive understanding of the interactions of accumulated nanoparticles with the spleen using dynamic chip models. 3.4. Excretory system The human kidney is the main excretory organ that is exposed to drugs, and it is comprised of multiple cell types, including glomerular vascular endothelial cells and podocytes, performs many vital functions, including endocrine functions and cellular metabolism, and possesses a variety of critical structural components, including precisely arranged renal tubular segments and transcellular electrochemical and osmotic pressure gradients [136,137]. In particular, the epithelial cells of the proximal renal tubules in the kidney are the most susceptible targets for nanomedicine due to their capacity for drug metabolism [138]. The emergence of Kidney-on-a-chip (Kidney Chip). The Ingber Lab has created a Kidney Chip that mimics the in vivo renal tubular environment using human proximal tubular cells [139]. Under dynamic flow conditions mimicking living kidney tubules, superior primary cilia formation, epithelial cell polarization, albumin transport, glucose reabsorption, and brush border alkaline phosphatase activity were observed compared to cells cultured under static conditions. Additionally, the dynamic conditions revealed that exposure to apical fluid shear stress is important for facilitating cell recovery from cisplatin-induced damage and enhances em P /em -glycoprotein (Pgp) efflux transporter activity, two features observed in vivo that are not reflected in conventional cell culture models. Hence, the human Kidney Chip is a platform that can meet the demand for mimicking human drug clearance and metabolism through precise control of drug concentrations and fluid flow rates [140]. Tracking Propyzamide nephrotoxicity using nanoparticulates upon Kidney Chip. To date, investigations of nanotherapeutic applications using the Kidney Chip have yet to be reported. Nevertheless, there has been one study in which nanoparticles were Propyzamide introduced as an imaging adjuvant for kidney injury [93]. -Glutamyl transpeptidase (GGT) is a protein presented on the apical membrane of proximal tubular cells (786-O) that is released upon cytotoxic insult. Therefore, introducing 500-nm fluorescent polystyrene nanoparticles conjugated with em anti /em -GGT antibodies within the apical channel provided tracking capabilities of drug-induced nephrotoxicity due to agglutination of the nanoparticles upon immunocapture of released GGT, corresponding to increased fluorescence measured in the outflow (Fig. 4A). Interestingly, A smartphone-based fluorescence microscope was integrated as a handheld monitoring device attached to the chip (Fig. 4B), which provided a novel groundbreaking tool to enable the internal and external monitoring of the Sirt6 Kidney Chip. As such, this nanoparticle-based strategy overcomes the challenge of assessing cellular responses during chip experiments in a quick, real-time, non-disruptive, and in situ manner. Open in a separate window Fig. 4 The incorporation of nanoparticles into Kidney Chip enables in situ monitoring of nephrotoxicity. (A) Schematic illustration of nephrotoxicity detection using nanoparticle-based strategy. (B) In situ monitoring Kidney Chip by a smartphone-based fluorescence microscope. Reproduced from Reference [93]. Copyright 2016?Elsevier BV. Outlook of using Kidney Chip in the study of nanomedicine. In recent years, highly sophisticated Kidney Chip platforms have been further developed using strategies such as 3D (bio)printing and induced pluripotent stem cells (iPSC)-derived podocytes [136,141]. As novel developments in Kidney Chip technology arise to integrate additional cell types and functions, there is an opportunity for more comprehensive research regarding the clearance of nanoparticles, particularly those smaller than 10?nm in diameter that will experience.